This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objectives A machine learning technique for identifying hidden coronary artery disease (CAD) might be useful. We developed and validated machine learning models to predict patients with hidden CAD and to assess long-term outcomes in patients with acute ischemic stroke.
Methods Multidetector coronary CT was performed for patients without a known history of CAD. Primary outcomes were defined as having any degree of CAD and having obstructive CAD (≥50% stenosis). Demographic variables, risk factors, laboratory results, Trial of ORG 10172 in Acute Stroke Treatment classification, NIH Stroke Scale score, blood pressure, and carotid artery stenosis were used to develop and validate machine learning models to predict CAD. Area under the receiver operating characteristic curves (AUC) was calculated for performance analysis, and Kaplan-Meier and Cox survival analyses of long-term outcomes were performed. Major adverse cardiovascular events (MACEs) were defined as ischemic stroke, myocardial infarction, unstable angina, urgent coronary revascularization, and cardiovascular mortality.
Results Overall, 1,710 patients were included for the training dataset and 348 patients for the validation dataset. An extreme gradient boosting model was developed to predict any degree of CAD, which showed an AUC of 0.763 (95% CI 0.711–0.814) on validation. A logistic regression model was used to predict obstructive CAD and had an AUC of 0.714 (95% CI 0.692–0.799). During the first 5 years of follow-up, MACEs occurred more frequently with predictions of any CAD (p = 0.022) or obstructive CAD (p < 0.001). Cox proportional analysis showed that the hazard ratio of MACE was 1.5 (95% CI 1.1–2.2; p = 0.016) with prediction of any CAD, whereas it was 1.9 (95% CI 1.3–2.6; p < 0.001) for obstructive CAD.
Discussion We demonstrated that machine learning may help identify hidden CAD in patients with acute ischemic stroke. Long-term outcomes were also associated with prediction results.
Classification of Evidence This study provides Class II evidence that in patients with acute ischemic stroke with CAD risk factors but no known history of CAD, a machine learning model predicts CAD on multidetector coronary CT with an AUC of 0.763 (95% CI 0.711–0.814).
Glossary
- AUC=
- area under the receiver operating characteristic curve;
- CAD=
- coronary artery disease;
- HDL=
- high-density lipoprotein;
- LDL=
- low-density lipoprotein;
- MACE=
- major adverse cardiovascular event;
- MDCT=
- multidetector coronary CT;
- NIHSS=
- NIH Stroke Scale;
- TOAST=
- Trial of ORG 10172 in Acute Stroke Treatment;
- XGBoost=
- extreme gradient boosting
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editors were Brad Worrall, MD, MSc, FAAN, and José Merino, MD, MPhil, FAAN.
Editorial, page 13
Class of Evidence: NPub.org/coe
CME Course: NPub.org/cmelist
- Received October 11, 2021.
- Accepted in final form March 2, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
